The Ophthalmologist / Issues / 2025 / July / Allen C. Ho Power List Perspectives / Notecards
Retina Insights Opinions

Allen C. Ho Power List Perspectives

Our 2025 Power Lister winners take a look at current trends in their subspecialties

By Julian Upton 7/25/2025 3 min read

Share

article Full Article subject Summary summarize Notecard

  • Allen C. Ho is a leading figure in retinal research.

  • Advancements in translational science are enhancing treatment for retinal diseases.

  • Diabetic retinopathy and AMD are key focus areas.

  • Over 30 gene therapies have been approved since 2017.

  • Eye-specific gene therapies are anticipated in the next five years.

  • The retinal innovation ecosystem is deemed robust.

About the Author(s)

Julian Upton

Julian Upton is Group Editor of The Ophthalmologist and The New Optometrist. With 20+ years' experience of the magazine industry, he has covered many facets of science and healthcare.

More Articles by Julian Upton

Related Content

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: